Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Nov 11 (Reuters) - Morgan Stanley (MS.N), opens new tab launched a dedicated private company research page on Tuesday, according to an internal memo seen by Reuters, as investors' interest in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback